Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02869217
Title Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

Advanced Solid Tumor

Therapies

Cyclophosphamide + Fludarabine

TBI-1301

Age Groups: adult | child | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Princess Margaret Cancer Centre Recruiting Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field